Athyros VG , Papageorgiou AA , Mercouris BR et al. Treatment with atorvastatin to the National Cholesterol Educational Program goals versus usual care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . Curr Med Res Opin2002;4:220-8.
2.
Athyros VG , Papageorgiou AA , Symeonidis AN et al. Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . Angiology2003;54:679-90.
3.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . JAMA2001;285:2486-97.
4.
Milionis HJ , Elisaf MSManagement of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: Case histories . Curr Med Res Opin2000;16:164-70.
5.
Fried LF , Orchard TJ , Kasiske BL , for the Lipids and Renal Disease Progression Meta-Analysis Study Group.Effect of lipid reduction on the progression of renal disease: A meta-analysis . Kidney Int2001;59:260-5.
6.
Heart Protection StudyCollaborative Group.MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial . Lancet2003;361:2005-16.
7.
Athyros VG , Mikhailidis DP , Papageorgiou AA et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . J Clin Pathol2004;(in press).
8.
Athyros VG , Elisaf M. , Papageorgiou AA et al. The effect of statins versus untreated dyslipidaemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study . Am J Kidney Dis2004;(in press).
9.
Papadakis JA , Milionis HJ , Press M. , Mikhailidis DPTreating dyslipidaemia in non-insulin dependent diabetes mellitus (NIDDM) - a special reference to statins . J Diabetes Complicat2001;15:211-26.
10.
Youssef F. , Seifalian AM , Jagroop IA et al. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT) . Eur J Vasc Endovasc Surg2002;23:358-64.
11.
Youssef F. , Gupta P. , Seifalian AM et al. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease . Angiology2004;55:53-62.
12.
Kakafika A. , Liamis G. , Elisaf M. , Mikhailidis D.Effect of atorvastatin on serum creatinine levels . Curr Med Res Opin2001;17:230-1.
13.
Athyros VG , Papageorgiou AA , Elisaf M. et al. Statins and renal function in patients with diabetes mellitus . Curr Med Res Opin2003;19:615-17.
14.
Dahlof B. , Devereux RB , Kjeldsen SE et al; The LIFE Study Group.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol . Lancet2002;359:995-1003.
15.
Hoieggen A. , Alderman MH , Kjeldsen SE et al. LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study . Kidney Int2004;65:1041-9.
16.
Daskalopoulou SS , Athyros VG , Elisaf M. , Mikhailidis DPUric acid levels and vascular disease . Curr Med Res Opin2004;(in press).
